References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
GuertinandSabatini(2009)ThepharmacologyofmTORinhibition.Sci.Signal.2pe24PMID:19383975
Thoreenetal(2009)AnATP-competitivemammaliantargetofrapamycininhibitorrevealsrapamycin-resistantfunctionsofmTORC1.J.Biol.Chem.2848023PMID:19150980
Liuetal(2010)Discoveryof1-(4(-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-oneasahighlypotent,selectivemammaliantargetofrapamycin(mTOR)inhibitorforthetreatmentofcancer.J.Med.Chem.537146PMID:20860370
Petersonetal(2011)mTORcomplex1regulateslipin1localizationtocontroltheSREBPpathway.Cell.146408PMID:21816276
Galluzzietal(2017)Pharmacologicalmodulationofautophagy:therapeuticpotentialandpersistingobstacles.Nat.Rev.Drug.Discov.PMID:28529316
Keywords:Torin1,supplier,Torin1,mtor,mammalian,target,rapamycin,inhibitors,inhibits,potent,selective,mTOR,Autophagy,mTOR,TocrisBioscience